BRKRP Bruker Corporation
$420.49
Platform & Compounding FCF 50%
Two-stage FCF DCF
Strong · Conviction

Overvalued

Trading 106834.4% above fair value

You pay $420.49
Bear $0.00
Fair $0.39
Bull $2.82
Bear $0.00 -100.0% 5% stage 1 growth, 12% discount
Fair $0.39 -99.9% 9% stage 1 growth, 12% discount
Bull $2.82 -99.3% 11% stage 1 growth, 12% discount

Adjust Assumptions

8.6%
12.0%
3.0%

Key Value Driver

FCF growth rate (9% base case)

Terminal Value % of EV 33%
Implied Market Multiple 618.5x
Market is pricing in (growth) 59.2% vs 8.6% base

Summary

Using a two-stage FCF DCF with 9% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $0.39 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions